Lifescan Corporation

Lifescan Scotland Limited

Animas Corporation

Diabetes Diagnostics, Inc.

Ulrich Kraft

Manfred Ebner

Peter A Krulevitch

Robert A Wilk

Zara Sieh

Nick Foley

James Glencross

Donna L Savage

David Shepherd

Donna Savage

David K Hohl

Carl M Brewer

Krzysztof Z Brukalo

Steven Getz

Sieghard Hasenzahl

Mark DeStefano

James Christol

Mahyar Zardoshti Kermani

David Price

David Elder

Eric D Bailey

Pinaki Ray

Eric Jason Bailey

Mark H Olson

John Christopher Davis

Mary McEvoy

Katherine D Crothall

Joseph McCluskey

David Taylor

Greg Matian

Murphy Freelen

Barbara A Montgomery

Mitch Zhao

Carrie Arndt

Rainer R Teucher

Lars H Berger

Elizabeth A Cummings

David M D Price

Matthias Steine

Matthias Stiene

Rainer Rudolf Teucher

Lars Helmut Berger

Elizabeth Anne Cummings

Mary Ellen Mcevoy

Joseph Mccluskey

Various embodiments of a 'smart' drug delivery pen are provided which include a drug delivery pen having an inertial sensor or accelerometer. A system is also provided that includes the smart drug pen in conjunction with a data management unit(s) DMU. Various exemplary methods for use of the pens and systems are also described and illustrated.

Drug delivery management systems and methods

A method of operating a glucose test meter is provided. The method can be achieved by storing a plurality of glucose readings to a first memory of the test meter, each of the glucose readings having a time stamp and an order index, the time stamp comprising a date and a time when the glucose reading was performed, the order index indicating an order in which the plurality of glucose readings was saved to the first memory; determining whether successively saved glucose readings have time stamps in chronological order consistent with the order index; and indicating that the date and the time setting in the test meter is incorrect if there are successively saved glucose readings having time stamps inconsistent with the order index.

Method of ensuring date and time on a test meter is accurate

A disease management system, methods, and devices are shown and described. In one embodiment, the system includes an infusion pump and a remote controller with the ability to be paired to each other. A method to verify a wireless connection between an infusion pump and a remote controller is shown and described herein. In a further embodiment, a method to verify a wireless connection between an infusion pump and a remote controller is provided. In addition, a method of operating a diabetes management system is provided in which the system includes an infusion pump and at least a remote controller.

Systems and methods to pair a medical device and a remote controller for such medical device

The present invention relates to a method for wireless transmission of data between components of a blood glucose system (, I) including a master controller (') having a receiver () and a transmitter (), and at least one slave device () having a receiver () and a transmitter (). The slave device () is normally operated in a power saving mode and its receiver () is only activated intermittently at a receiver activation frequency for a predetermined listening period. The controller () transmits a communication initiation data frame to the slave device () via a preamble signal transmitted for a preamble period. Upon receipt of the communication initiation data frame, the slave device () is switched to a communication mode in which it transmits a response to the controller (), and the slave device () is switched from the communication mode to the power saving mode.

Method for transmitting data in a blood glucose system and corresponding blood glucose system

A hand-held test meter for use with an analytical test strip in the determination of an analyte in a bodily fluid sample includes a housing; a microcontroller block disposed in the housing; and a phase-shift-based hematocrit measurement block. The phase-shift-based hematocrit measurement block includes a signal generation sub-block, a low pass filter sub-block, an analytical test strip sample cell interface sub-block, a transimpedance amplifier sub-block, and a phase detector sub-block. In addition, the phase-shift-based hematocrit measurement block and microcontroller block are configured to measure the phase shift of a bodily fluid sample in a sample cell of an analytical test strip inserted in the hand-held test meter and the microcontroller block is configured to compute the hematocrit of the bodily fluid sample based on the measured phase shift.

Hand-held test meter with phase-shift-based hematocrit measurement circuit

Various embodiments of a 'smart' drug delivery system are provided which includes an add-on module and a reusable or disposable drug pen in conjunction with a data management unit(s) DMU. Upon attachment to the pen, the add-on module may: determine dosage selected, injection of selected dosage, duration of injection, time of injection, whether the pen has been primed or shaken to thoroughly mix up insulin mixtures, transmit information relating to insulin dosage and injection to a data management unit, provide reminders, error warning or messages on improper usage or reuse of needles, track amount of drug remaining on board the pen or duration of usage of pen with respect to expiry of the drug on board, or provide an audible alarm for locating misplaced pen and module. Methods of using the drug delivery system are also described.

Various embodiments of a 'smart' drug delivery system are provided which includes an add-on module and a reusable or disposable drug pen. Upon attachment to the pen, the add-on module may: determine dosage selected, injection of selected dosage, duration of injection, time of injection, whether the pen has been primed or shaken to thoroughly mix up insulin mixtures, transmit information relating to insulin dosage and injection to a data management unit, provide reminders, error warning or messages on improper usage or reusage of needles, track amount of drug remaining on board the pen or duration of usage of pen with respect to expiry of the drug on board, or provide an audible alarm for locating misplaced pen and module.

Drug delivery system

Various embodiments of a medical module are provided which includes a primary module housing, a secondary module housing, a dosage sensor, a power source, and a microcontroller. The module is configured to be attached to a disposable drug delivery pen or a reusable drug delivery pen so that the module may: determine dosage selected, injection of selected dosage, duration of injection, time of injection, whether the pen has been primed or shaken to thoroughly mix up insulin mixtures, transmit information relating to insulin dosage and injection to a data management unit, provide reminders, error warning or messages on improper usage or reusage of needles, track amount of drug remaining on board the pen or duration of usage of pen with respect to expiry of the drug on board, or provide an audible alarm for locating misplaced pen and module.

Medical module for drug delivery pen

A method for wireless transmission of data between a master controller (') having a receiver () and a transmitter (), and at least one slave device () having a receiver () and a transmitter (), and to a corresponding blood glucose system (). The slave device () is normally operated in a power saving mode in which its receiver () is only activated intermittently at a receiver activation frequency for a predetermined listening period. The controller () transmits a communication initiation data frame to the slave device () by means of a signal comprising a preamble signal transmitted for a preamble period. Upon receipt of the communication initiation data frame, the slave device () is switched to a communication mode in which it transmits a response to the controller (), and the slave device () is switched from the communication mode to the power saving mode.

Method of operating a medical device and at least a remote controller for such medical device

The invention relates to a method for wireless transmission of data between components of a blood glucose system including a master controller (i.e., 'master') and a slave device (i.e., 'slave'). The master and slave each have a receiver and transmitter. The method comprises operating the slave normally in a power saving mode, activating the transmitter of the master for a transmission period and subsequently activating the receiver of the master for a response period. When the slave receives a preamble signal during a listening period the slave receiver is activated until a portion of a transmitted data frame from the master is received, switched into a communication mode to transmit a response to the master and switched from the communication mode to the power saving mode. In the power saving mode the activation frequency of the slave receiver and the transmission of the data frame are controlled to save power.

A system and method of processing a test current for an analyte measurement in a fluid using a test strip and a test meter are disclosed. The method comprises sampling the test current at a pre-determined sampling rate to acquire a plurality of A/D conversions. The method also comprises filtering out at least a highest magnitude A/D conversion and a lowest magnitude A/D conversion leaving a plurality of accepted A/D conversions. Further, the method comprises calculating an average or a summation of the plurality of accepted A/D conversions and converting the average or the summation into a glucose concentration.

System and method of processing a current sample for calculating a glucose concentration

The present invention is a testing device for testing analyte levels in bodily fluids. The testing device comprises memory () for storing data, said data being analyte data related to analyte measurements carried out by the meter and lifestyle data; initiation means () for initiating immediate entry of data related to a specific category of lifestyle data; navigation means () for entry and navigation of said data; and transfer means () for transferring said data to said memory. Preferably, the testing device is a glucose meter and one of the analytes being tested is glucose.

Analyte testing device

Growing community of inventors

Hofheim, Germany

Ulrich Kraft